Showing results (101-110 of 241) with videos related to

Sort By:
Pageof 25
Scientific Reports|March 4, 2016
Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biologyKatharina Tatzel, Lindsay Kuroki, Igor Dmitriev, et al.
BMC Cancer|March 13, 2022
The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancerPratibha S Binder, Yassar M Hashim, James Cripe, et al.
Gynecologic Oncology|October 8, 2013
Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancerAndrea R Hagemann, Akiva P Novetsky, Israel Zighelboim, et al.
Gynecologic Oncology|November 21, 2025
AXL inhibition improves the therapeutic efficacy of trastuzumab in high-risk endometrial cancerJo'an Tankou, Sofia Ruau, Anjali Walia, et al.
Obstetrics and Gynecology|October 10, 2013
Disclosing a diagnosis of cancer: considerations specific to gynecologic oncology patientsLindsay M Kuroki, Qiuhong Zhao, Donna B Jeffe, et al.
Scientific Reports|March 17, 2024
The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancerTakaomi Hagi, Suwanna Vangveravong, Rony Takchi, et al.
American Journal of Obstetrics and Gynecology|July 27, 2016
Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patientsPratibha S Binder, Jeffrey F Peipert, D Kallogjeri, et al.
Gynecologic Oncology|December 3, 2014
A cost-effectiveness analysis of a chemoresponse assay for treatment of patients with recurrent epithelial ovarian cancerVictoria Plamadeala, Joseph L Kelley, John K Chan, et al.
Gynecologic and Obstetric Investigation|August 13, 2018
Gynecologic Oncologists' Perceptions of Palliative Care and Associated Barriers: A Survey of the Society of Gynecologic OncologyJames C Cripe, Kathryn A Mills, Lindsay K Kuroki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 2006
DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesisNicholas P Taylor, Israel Zighelboim, Phyllis C Huettner, et al.
Pageof 25